“…While MSMDs were initially recognized for their distinct susceptibility to mycobacteria (particularly non-tuberculous (NTM) and occasionally M. tuberculosis ) and Salmonella (predisposing victims to extra-intestinal salmonellosis) [ 38 , 39 , 150 , 151 , 152 , 153 , 154 ], they were also subsequently found in patients with otherwise unexplained disseminated TDEF infection, including histoplasmosis (IL12RB1 [ 153 , 155 , 156 , 157 ]; IFNGR1 [ 158 ]), coccidioidomycosis (IFNGR1 [ 159 ] and IL12RB1 [ 160 ]), and paracoccidioidomycosis (IL12RB1 [ 161 ]). These findings provided the framework of human immunity to TDEF, which was followed by the identification of other IEI congruent with defective IFN-γ-mediated immunity, including CD40L deficiency [ 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 ] (discussed further in the section on “Pneumocystis”), GATA2 deficiency [ 171 ], and STAT1 GOF [ 168 , 169 , 172 , 173 ].…”